Search

Search Constraints

You searched for: Author/Creator Fornecker, Luc-Matthieu

Search Results

1. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Issue 2 (22nd July 2022)

3. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO). Issue 5 (23rd October 2020)

5. Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study. (November 2021)

6. Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011). Issue 29 (10th October 2021)

7. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study. (10th March 2020)

8. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study. Issue 2 (February 2019)

9. PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma – Authors' reply. Issue 4 (April 2019)

10. Rituximab-Lenalidomide-Ibrutinib Combination for Relapsed/Refractory Primary CNS Lymphoma: A Case Series of the LOC Network. (28th September 2021)